EP Patent

EP4178555A4 — IMPROVED HIGHLY EFFICIENT PROCESS FOR THE PREPARATION OF NINTEDANIB AND A PHARMACEUTICAL GRADE SALT THEREOF

Assigned to Bdr Lifesciences Private Ltd · Expires 2024-08-07 · 2y expired

What this patent protects

Patent listed against nintedanib-esylate.

Drugs covered by this patent

nintedanib-esylate (NINTEDANIB ESYLATE)

Patent Metadata

Patent number: EP4178555A4
Jurisdiction: EP
Classification: —
Expires: 2024-08-07
Drug substance claim: No
Drug product claim: No
Assignee: Bdr Lifesciences Private Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.